<![CDATA[Leveraging the CD44-SPP1 Axis in Muscle-Invasive Bladder Cancer]]>

Summary: Scientists are learning exactly how bladder cancer tricks the body. In late-stage bladder cancer, tumors create a special shield using a connection between two proteins called CD44 and SPP1. This sneaky combo "brainwashes" the body's immune cells, making them protect the tumor instead of fighting it. Because of this, standard chemotherapy treatments often stop working.

Now, researchers are testing new ways to block this CD44-SPP1 connection. By breaking this shield, they hope to make the cancer weak against treatments again. They are even looking at using specially engineered immune cells to attack the tumor directly.

Source: cancernetwork URL: cancernetwork.com/view/leveraging-the-cd44-spp1-axis-in-muscle-invasive-bladder-cancer (opens in new tab)